{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7466,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a complex biological pathway diagram and three supporting charts (penetration depth, accumulation over time, and apoptosis efficacy).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/36",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/37",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/38",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a comparative layout to position NXC-201 as a superior, one-time monotherapy against current multi-drug, weekly treatment regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/39",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide uses a step-wise process diagram to illustrate dose escalation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/40",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays clinical trial data for NXC-201, specifically focusing on safety profiles and management of side effects.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/41",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide highlights specific safety data points for Arcellx's product, likely for competitive benchmarking purposes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/42",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/43",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table compares clinical trial inclusion criteria across four different therapies, focusing on prior lines of therapy, toxicity recovery, ECOG status, and measurable disease definitions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/44",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide highlights that NXC-201 has no exclusion for prior BCMA therapy, unlike the other listed treatments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/45",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bar chart to contrast the combined market size of two groups of drugs ($33.4bn vs $0.9bn).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/46",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide contains three distinct data charts comparing IMX-110 against standard treatments in mouse models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/47",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a process flow diagram illustrating the mechanism of action of iMX-110 in tumor microenvironments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/48",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes unpublished internal data alongside referenced Winograd et al. 2015 study.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/49",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide compares two cohorts: Soft Tissue Sarcoma and Non-Sarcoma Cancers, using line charts for longitudinal change and bar charts for best response.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/50",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a bubble chart to map clinical trial outcomes and a table to detail specific drug performance metrics across treatment lines.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/51",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart on the left is a conceptual visualization rather than a standard data plot, emphasizing the 100% heavily pre-treated patient population.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/52",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to illustrate the clinical development path for two different treatment regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/53",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes comparative size illustration of IMX-111 vs IgG antibody, and survival curve data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/54",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume over time and survival curves for two different cancer models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/55",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-55",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 56,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a mix of mechanism-of-action diagrams, clinical trial bar charts, and preclinical mouse model data to validate the therapeutic approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/56",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-56",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 57,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/57",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-57",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 58,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a side-by-side comparison structure to explain two distinct but complementary proprietary platforms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/58",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-58",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 59,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow style layout to connect platform capabilities to specific product outputs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/59",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-59",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 60,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The process flow is non-linear, moving left-to-right on the top row (1-5) and right-to-left on the bottom row (6-10).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/60",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-60",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 61,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a 3-pillar framework to explain the platform, then maps these to specific drug candidates with detailed mechanism-of-action descriptions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/61",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-61",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 62,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/62",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-62",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7f75-7018-9745-0295f8cc0604",
      "docSlug": "ff20cbe040f7db4fd450e0597505890e",
      "documentTitle": "Innovid | Investor Day Presentation Deck | 74 slides",
      "authorId": "innovid",
      "authorName": "Innovid",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/csadAQsxrdkXeU3WSIWlMFysOjr6OXrDItrJMJBfxv4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZjIwY2JlMDQwZjdkYjRmZDQ1MGUwNTk3NTA1ODkwZS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7f75-7018-9745-0295f8cc0604/1",
      "deckHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604",
      "deckAnchorHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/np4ZR3L75KxrkCWWRppHwN163qrRJV-Jj2efbT6ic4A/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZjIwY2JlMDQwZjdkYjRmZDQ1MGUwNTk3NTA1ODkwZS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/5Gxfn_IHPB48tV81suw6sRVciymVRaOZnIDUDlu6fvg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZjIwY2JlMDQwZjdkYjRmZDQ1MGUwNTk3NTA1ODkwZS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/l6uvdj7UbgX2FKgNZsvJ_deEvmBD0nSiV9DnJeNNk9c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZjIwY2JlMDQwZjdkYjRmZDQ1MGUwNTk3NTA1ODkwZS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-7f75-7018-9745-0295f8cc0604",
      "docSlug": "ff20cbe040f7db4fd450e0597505890e",
      "documentTitle": "Innovid | Investor Day Presentation Deck | 74 slides",
      "authorId": "innovid",
      "authorName": "Innovid",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7f75-7018-9745-0295f8cc0604/2",
      "deckHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604",
      "deckAnchorHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7f75-7018-9745-0295f8cc0604",
      "docSlug": "ff20cbe040f7db4fd450e0597505890e",
      "documentTitle": "Innovid | Investor Day Presentation Deck | 74 slides",
      "authorId": "innovid",
      "authorName": "Innovid",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-7f75-7018-9745-0295f8cc0604/3",
      "deckHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604",
      "deckAnchorHref": "/decks/019de076-7f75-7018-9745-0295f8cc0604#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}